• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国研究机构的科研相关伤害补偿政策。

Research-related injury compensation policies of U.S. research institutions.

作者信息

Resnik David B, Parasidis Efthimios, Carroll Kelly, Evans Jennifer M, Pike Elizabeth R, Kissling Grace E

出版信息

IRB. 2014 Jan-Feb;36(1):12-9.

PMID:24649739
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3991013/
Abstract

Federal research regulations require participants to be informed about whether medical care or compensation for injury is available in more than minimal risk studies and prohibit language in informed consent documents that waives, or appears to waive, legal rights. The objectives of this study were to compare data collected in 2000 and 2012 to identify significant changes in types of institutional compensation policies at U.S. research institutions, and assess the relationship between institutional characteristics and different types of policies. We found that research-related injury compensation policies did not change substantially during the time period. A significant percentage of policies contain language that can be reasonably interpreted as waiving, or appearing to waive, legal rights. Level of funding, public vs. private status, and institutional involvement in clinical research were associated with different types of policies. The lack of substantial change in compensation policies supports arguments for a national policy.

摘要

联邦研究法规要求,在风险超过最低限度的研究中,需告知参与者是否可获得医疗护理或伤害赔偿,并且禁止在知情同意文件中出现放弃或看似放弃合法权利的措辞。本研究的目的是比较2000年和2012年收集的数据,以确定美国研究机构机构赔偿政策类型的重大变化,并评估机构特征与不同类型政策之间的关系。我们发现,在这一时期,与研究相关的伤害赔偿政策没有实质性变化。很大一部分政策包含的措辞可被合理地解释为放弃或看似放弃合法权利。资金水平、公立与私立性质以及机构参与临床研究的情况与不同类型的政策相关。赔偿政策缺乏实质性变化支持了制定国家政策的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1090/3991013/8ac41b04908e/nihms-562856-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1090/3991013/eb007064fda0/nihms-562856-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1090/3991013/8ac41b04908e/nihms-562856-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1090/3991013/eb007064fda0/nihms-562856-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1090/3991013/8ac41b04908e/nihms-562856-f0002.jpg

相似文献

1
Research-related injury compensation policies of U.S. research institutions.美国研究机构的科研相关伤害补偿政策。
IRB. 2014 Jan-Feb;36(1):12-9.
2
India's regulatory reforms on compensation for clinical trial injuries and deaths: urgent need for revisiting.印度关于临床试验伤害与死亡赔偿的监管改革:亟需重新审视。
Indian J Med Ethics. 2013 Jul-Sep;10(3):195-7. doi: 10.20529/IJME.2013.057.
3
New rules for clinical trial-related injury and compensation.临床试验相关伤害与赔偿的新规定。
Indian J Med Ethics. 2013 Jul-Sep;10(3):197-200. doi: 10.20529/IJME.2013.058.
4
Moore revisited: state-sponsored biotechnological research and the takings clause.重温摩尔案:国家资助的生物技术研究与征收条款
Whittier Law Rev. 2001 Winter;23(2):437-65.
5
Compensation for research injuries.研究损伤的赔偿。
IRB. 2005 May-Jun;27(3):11-5.
6
New regulations on compensation for injury and death in drug trials.药物试验中伤亡赔偿新规定。
Indian J Med Ethics. 2013 Apr-Jun;10(2):76-9. doi: 10.20529/IJME.2013.026.
7
Research-related injury: problems and solutions.与研究相关的伤害:问题与解决方案。
J Law Med Ethics. 2003 Fall;31(3):419-28. doi: 10.1111/j.1748-720x.2003.tb00104.x.
8
Appropriateness of no-fault compensation for research-related injuries from an African perspective: an appeal for action by African countries.从非洲视角看研究相关伤害无过错补偿的适宜性:呼吁非洲国家采取行动
J Med Ethics. 2016 Aug;42(8):528-33. doi: 10.1136/medethics-2014-102246. Epub 2016 Jun 3.
9
Human research subjects as human research workers.作为人类研究工作者的人类研究对象。
Yale J Health Policy Law Ethics. 2014 Winter;14(1):122-93.
10
The Quest for Compensation for Research-Related Injury in the United States: A New Proposal.美国寻求与研究相关伤害的赔偿:一项新提案。
J Law Med Ethics. 2019 Dec;47(4):732-747. doi: 10.1177/1073110519897737.

引用本文的文献

1
Vulnerable Research Participant Policies at U.S. Academic Institutions.美国学术机构中易受伤害的研究参与者政策。
J Empir Res Hum Res Ethics. 2024 Oct;19(4-5):220-225. doi: 10.1177/15562646241290093. Epub 2024 Oct 17.
2
Conflicts of interest in institutional review boards are a threat to ethical research.机构审查委员会中的利益冲突对伦理研究构成威胁。
Nat Med. 2023 Nov;29(11):2701-2703. doi: 10.1038/s41591-023-02442-0.
3
Ethical Criteria for Improved Human Subject Protections in Phase I Healthy Volunteer Trials.提高 I 期健康志愿者试验中人类受试者保护的伦理标准。

本文引用的文献

1
Recovering from research: a no-fault proposal to compensate injured research participants.从研究中恢复:一项补偿受伤害研究参与者的无过错提议。
Am J Law Med. 2012;38(1):7-62. doi: 10.1177/009885881203800101.
2
Compensation for research-related injuries. Ethical and legal issues.与研究相关损伤的补偿。伦理与法律问题。
J Leg Med. 2006 Sep;27(3):263-87. doi: 10.1080/01947640600870866.
3
Compensation for injured research subjects.对受伤害研究对象的补偿。
Ethics Hum Res. 2022 Sep;44(5):2-21. doi: 10.1002/eahr.500139.
4
"Choice of law" in precision medicine research.精准医学研究中的“法律选择”。
Am J Hum Genet. 2022 Aug 4;109(8):1347-1352. doi: 10.1016/j.ajhg.2022.06.009.
5
Avoiding Exploitation in Phase I Clinical Trials: More than (Un)Just Compensation.避免I期临床试验中的剥削:不仅仅是(不)公正补偿
J Law Med Ethics. 2018 Mar;46(1):52-63. doi: 10.1177/1073110518766008. Epub 2018 Mar 27.
6
Institutional Conflict of Interest Policies at U.S. Academic Research Institutions.美国学术研究机构的机构利益冲突政策。
Acad Med. 2016 Feb;91(2):242-6. doi: 10.1097/ACM.0000000000000980.
7
Unequal treatment of human research subjects.对人类研究对象的不平等对待。
Med Health Care Philos. 2015 Feb;18(1):23-32. doi: 10.1007/s11019-014-9569-6.
N Engl J Med. 2006 May 4;354(18):1871-3. doi: 10.1056/NEJMp068080.